《大行》美銀:Lululemon(LULU.US)首季略勝預期 重申「買入」評級
美銀發表研究報告指,Lululemon(LULU.US)首季每股盈利2.6美元,略高於該行預測的2.57美元,相信是由於期內收入及毛利率表現更強勁,惟部分被較高的銷售開支所抵銷。管理層維持2025財年銷售指引,但將全年每股盈利指引下調2.5%至14.58至14.78美元,以反映關稅政策及促銷活動預期增加的影響。相應地美銀將Lululemon 2025及2026財年每股盈利預測下調2%,目標價從400美元下調至370美元。美銀表示,中國業務將繼續是Lululemon的最大增長機遇,重申「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.